Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice by Marie-Lynn Cuypers, Nick Geukens, Kevin Hollevoet, Paul Declerck, Maarten Dewilde

Get full text

Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians by Liese Barbier, Yannick Vandenplas, Steven Simoens, Paul Declerck, Arnold G. Vulto, Isabelle Huys

Get full text

Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis by Ruben Faelens, Zhigang Wang, Thomas Bouillon, Paul Declerck, Marc Ferrante, Séverine Vermeire, Erwin Dreesen

Get full text

Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking by Liese Barbier, Steven Simoens, Paul Declerck, Arnold G. Vulto, Arnold G. Vulto, Isabelle Huys

Get full text

Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn’s di... by Nathalie Van den Berghe, Dahham Alsoud, Bram Verstockt, Séverine Vermeire, Paul Declerck, Debby Thomas

Get full text

Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice Messaging by Liese Barbier, Allary Mbuaki, Steven Simoens, Paul Declerck, Arnold G. Vulto, Arnold G. Vulto, Isabelle Huys

Get full text

Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model by Kevin Hollevoet, Kevin Hollevoet, Debby Thomas, Debby Thomas, Griet Compernolle, Griet Compernolle, Giles Vermeire, Elien De Smidt, Elien De Smidt, Stéphanie De Vleeschauwer, Trevor R. F. Smith, Paul D. Fisher, Maarten Dewilde, Maarten Dewilde, Nick Geukens, Paul Declerck, Paul Declerck

Get full text

Novel ELISA for the specific detection of protease NEXIN‐1 in human biological samples by Laurence Venisse, Déborah François, Célina Madjène, Els Brouwers, Emmanuelle deRaucourt, Yacine Boulaftali, Paul Declerck, Véronique Arocas, Marie‐Christine Bouton

Get full text

Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics by Jasmine Davda, Paul Declerck, Siwen Hu-Lieskovan, Timothy P. Hickling, Ira A. Jacobs, Jeffrey Chou, Shahram Salek-Ardakani, Eugenia Kraynov

Get full text

Anti-tau intrabodies: From anti-tau immunoglobulins to the development of functional scFv intrabodies by Dina Rodrigues Martins, Fern Sha, Wim Van der Elst, Pei-Yu Shih, Jens Devoght, Kristof Van Kolen, Marc Mercken, Bianca Van Broeck, Paul Declerck, Clara Theunis

Get full text

Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model by Maya Imbrechts, Wim Maes, Louanne Ampofo, Nathalie Van den Berghe, Bas Calcoen, Dominique Van Looveren, Winnie Kerstens, Madina Rasulova, Thomas Vercruysse, Sam Noppen, Rana Abdelnabi, Caroline Foo, Kevin Hollevoet, Piet Maes, Xin Zhang, Dirk Jochmans, Karen Ven, Jeroen Lammertyn, Karen Vanhoorelbeke, Nico Callewaert, Paul De Munter, Dominique Schols, Hendrik Jan Thibaut, Johan Neyts, Paul Declerck, Nick Geukens

Get full text